‘Paracetamol use during pregnancy doesn’t increase autism, ADHD risks’, Pg13

Key Highlights:

• A new study in The Lancet found that paracetamol use during pregnancy does not increase the risk of autism, ADHD, or intellectual disability in children.
• The study, led by researchers from City St George's, University of London, is the most rigorous analysis to date, based on 43 studies.
• The research team compared pregnancies where mothers took paracetamol to those where they did not, including sibling comparison studies.
• Data included 2,62,852 children assessed for autism, 3,35,255 for ADHD, and 4,06,681 for intellectual disability.

Detailed Insights:

• Previous claims linking paracetamol use during pregnancy to increased risks of autism were based on studies prone to bias and insufficient data.
• The sibling comparison study design helps control for shared genetics, family environment, and long-term parental characteristics.
• The study used the Quality in Prognosis Studies (QUiPS) tool to evaluate the risk of bias in the included studies.
• Researchers emphasize that avoiding paracetamol for significant pain or fever can expose both mother and baby to known risks.
• Paracetamol is globally recommended as a first-line option for pain relief and fever reduction during pregnancy due to its favorable safety profile.
• The findings support recommendations made by major medical organizations worldwide, reinforcing paracetamol as a safe option during pregnancy when taken as guided.

Key Concepts Involved:

• Autism: A neurodevelopmental disorder characterized by difficulties in social interaction and communication.
• ADHD: A chronic condition including attention difficulty, hyperactivity, and impulsiveness.
• Analgesic: A medication used to relieve pain.
• Antipyretic: A medication used to reduce fever.